Product Images Fosaprepitant
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Fosaprepitant NDC 16714-929 by Northstar Rxllc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
carton - carton
This is a description for Fosaprepitant for Injection. The injection is provided in a single-dose vial containing a sterile lyophilized powder equivalent to 150 mg of Fosaprepitant. The powder must be reconstituted with 5 mL of 0.9% Sodium Chloride for Injection, and the final drug solution must be used within 24 hours at a temperature of 25°C (77°F). Solutions containing divalent cations (such as Ca and Mg) should not be used for dilution. The injection is for intravenous use only and must be discarded if any portion is not used. Inactive ingredients include edetate disodium, polysorbate 80, lactose anhydrous, sodium hydroxide, and/or hydrochloric acid. The vials must be refrigerated at 2°C to 8°C (36°F to 46°F). This medication should be used only as prescribed; therefore, please read the accompanying directions carefully for preparation.*
label - label
structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.